Skandinaviska Enskilda Banken AB publ decreased its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 8.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 101,300 shares of the company’s stock after selling 9,800 shares during the period. Skandinaviska Enskilda Banken AB publ owned approximately 0.19% of Nu Skin Enterprises worth $5,626,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of Nu Skin Enterprises by 21,593.4% in the first quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock worth $371,201,000 after buying an additional 6,652,722 shares during the last quarter. Vanguard Group Inc. raised its stake in Nu Skin Enterprises by 11.8% in the first quarter. Vanguard Group Inc. now owns 6,011,632 shares of the company’s stock worth $333,887,000 after buying an additional 634,951 shares during the period. Wellington Management Group LLP raised its stake in Nu Skin Enterprises by 7.3% in the first quarter. Wellington Management Group LLP now owns 1,944,383 shares of the company’s stock worth $107,991,000 after buying an additional 131,493 shares during the period. Schroder Investment Management Group raised its stake in Nu Skin Enterprises by 139.4% in the first quarter. Schroder Investment Management Group now owns 1,711,619 shares of the company’s stock worth $94,687,000 after buying an additional 996,731 shares during the period. Finally, State Street Corp raised its stake in Nu Skin Enterprises by 76.7% in the first quarter. State Street Corp now owns 1,416,873 shares of the company’s stock worth $78,695,000 after buying an additional 614,817 shares during the period. Institutional investors own 85.54% of the company’s stock.
Nu Skin Enterprises, Inc. (NUS) opened at 63.06 on Friday. Nu Skin Enterprises, Inc. has a 12-month low of $44.95 and a 12-month high of $66.04. The stock has a market cap of $3.33 billion, a P/E ratio of 20.93 and a beta of 1.32. The company has a 50 day moving average of $58.20 and a 200-day moving average of $53.72.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.01. Nu Skin Enterprises had a net margin of 7.48% and a return on equity of 23.45%. The company had revenue of $499.10 million during the quarter, compared to analyst estimates of $493.65 million. During the same period in the prior year, the firm earned $0.42 earnings per share. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. Equities analysts forecast that Nu Skin Enterprises, Inc. will post $3.12 earnings per share for the current year.
WARNING: “Skandinaviska Enskilda Banken AB publ Has $5.63 Million Position in Nu Skin Enterprises, Inc. (NYSE:NUS)” was first reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.thestockobserver.com/2017/07/16/skandinaviska-enskilda-banken-ab-publ-sells-9800-shares-of-nu-skin-enterprises-inc-nus-updated-updated.html.
A number of brokerages have recently commented on NUS. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $70.00 price target on the stock in a report on Wednesday. Bank of America Corporation increased their target price on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a report on Monday, July 10th. Pivotal Research reaffirmed a “buy” rating and set a $80.00 target price (up previously from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. Deutsche Bank AG increased their price target on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Finally, ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $62.25.
In related news, General Counsel D Matthew Dorny sold 8,250 shares of the company’s stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $62.92, for a total value of $519,090.00. Following the completion of the sale, the general counsel now directly owns 46,730 shares of the company’s stock, valued at $2,940,251.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last ninety days, insiders sold 24,250 shares of company stock valued at $1,436,770. 5.20% of the stock is owned by insiders.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.